Page 2 - Endocrine Practice News Today

In this series, we evaluate some of the lesser-known yet common adverse events that are appearing in the ...

Transgender people who develop thromboembolism while on gender affirming hormone therapy be treated with the same regimen as cisgender patients.

Maintaining a healthy weight is necessary for your overall well-being. Some people are using artificial sweeteners thinking it will help them lose weight. But according to a review, using [...]

Individuals forced to switch to high-deductible plans appear to ration care, leading to more hypo- and hyperglycemic events.

Are artificial sweeteners bad for you? We weigh up the evidence on sugar substitutes

Sea kelp is a food product that reaches our kitchen from the oceans as a source of iodine and fiber. Let's take a look at kelp benefits 2023.

News and commentary from the endocrinology world

An unsystematic survey of the effect of SARS-COV-2, the virus, on sleeping individuals; and the effect of COVID-19, the disease, on populations.

email article The FDA accepted a new drug application and set a review date of October 31 for Marius Pharmaceuticals Kyzatrex, an oral testosterone undecanoate softgel, for primary and secondary male hypogonadism. The Endocrine Society released a new scientific statement calling for more research into the sex differences between males and females. ( Endocrine Reviews) The American Medical Association has recognized a CPT code (category III) for laser ablation of benign thyroid nodules und...

email article The FDA approved fosdenopterin (Nulibry) -- the first specific treatment for the rare metabolic disorder molybdenum cofactor deficiency type A. Hospitalized COVID-19 patients with low free T3 levels saw significantly higher rates of mortality, mechanical ventilation, and ICU admission. ( Endocrine Practice) Almost a quarter of patients with kidney stone disease also had osteoporosis or a fracture, according to a study of over 500,000 people. ( Journal of Bone and Mineral R...